CC
RXST icon

Centiva Capital’s RxSight RXST Stock Holding History

Centiva Capital’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$211K Buy
34,286
+18,725
+120% +$155K ﹤0.01% 1252
2025
Q4 		$162K Buy
+15,561
New +$156K ﹤0.01% 1017
2025
Q2 		– Sell
-28,815
Closed -$728K – 1978
2025
Q1 		$728K Buy
+28,815
New +$856K 0.02% 625
2024
Q2 		– Sell
-8,726
Closed -$450K – 2455
2024
Q1 		$450K Buy
+8,726
New +$428K 0.01% 1039

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Centiva Capital's RXST Position: Q1 2026 in Review

Centiva Capital increased its RxSight (RXST) stake by 120% in Q1 2026, buying an estimated $155K and bringing the position to 34,286 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #1252.

Centiva Capital first reported a position in RXST in Q1 2024 and has held it in 4 quarters since. The position peaked at $728K in Q1 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Centiva Capital held 34,286 shares of RxSight worth $211K as of Q1 2026.
  • Centiva Capital bought 18,725 RxSight shares in Q1 2026, an estimated $155K.
  • RxSight made up ﹤0.01% of Centiva Capital's portfolio in Q1 2026, its #1252 holding.
  • Centiva Capital first reported a position in RxSight in Q1 2024 and has held it in 4 quarters since.
  • Centiva Capital's RxSight position peaked at $728K in Q1 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.